- Bundibugyo Ebola outbreak in DRC and Uganda – where are the vaccines?
- Zimbabwe Dismantles 31 Drug Bases as Nearly 3 000 Suspects Are Taken to Court
- Africa Pushes Back Against US Travel Ban Linked to Ebola, Calls for Science-Driven Global Response
- In Zimbabwe, Relatives Could Now Be Called to Donate Blood for Patients
- US Suspends Entry of Travelers From Uganda, DRC Over Ebola Outbreak Fears
Bundibugyo Ebola outbreak in DRC and Uganda – where are the vaccines?
Published First on https://www.lshtm.ac.uk/ LSHTM Vaccine Centre Co-Director Dr Muhammed Afolabi discusses the Bundibugyo Ebola outbreak, the challenges of developing a vaccine against it and how to prepare for future outbreaks. On 17 May 2026 the World Health Organization (WHO) declared the outbreak of Ebola disease in the Democratic Republic of the Congo and Uganda
Read More
World Health Summit Regional Meeting 2026 Opens in Nairobi with Strong Call for Action on Resilient Health Systems
Michael Gwarisa NAIROBI, Kenya — The World Health Summit Regional Meeting 2026 officially opened in Nairobi on Sunday, bringing together more than 2,000 global health leaders, policymakers, researchers, and development partners to push for stronger and more resilient health systems across Africa and beyond. The high-level gathering is being held under the theme, Reimagining Africa’s
Read More
Israeli Prime Minister Benjamin Netanyahu Has Prostate Cancer
Michael Gwarisa Israel’s Prime Minister, Benjamin Netanyau was diagnosed with early-stage prostate cancer following routine post-surgical monitoring, but doctors say treatment was successful and the lesion has completely disappeared. According to an official medical report dated April 20, 2026, the Prime Minister had previously undergone treatment on December 29, 2024, for benign enlargement of the
Read More
Low Viral Load Doesn’t Mean Zero Risk: What New Uganda Study Means for U=U
Michael Gwarisa For years, the global HIV response has rallied around a simple but powerful message: Undetectable equals Untransmittable, widely known as U=U. Backed by strong scientific evidence, the concept has transformed both HIV prevention and the lives of people living with the virus. But new findings from the Rakai HIV Cohort Study in Uganda
Read More
Manchester Institute of Biotechnology Develops Cheaper, Sustainable Method to Produce HIV Drug Lenacapavir
Michael Gwarisa Amid growing global pressure to make Lenacapavir more affordable, researchers at the Manchester Institute of Biotechnology have developed a new method that could significantly reduce the cost and improve the sustainability of manufacturing the long-acting HIV prevention drug. Supported by funding from the Gates Foundation, the scientists applied engineering biology, a rapidly advancing
Read More
Mystery Haemorrhagic Illness Kills Five in Burundi
Michael Gwarisa The World Health Organization (WHO) is supporting Burundi’s efforts to determine the cause of an illness that has led to five deaths and infected 35 people in Mpanda district, north of the East African country. While preliminary assumptions linked the ailment to Ebola or Marburg virus diseases, Rift Valley fever, yellow fever and
Read More
Argentina withdraws from World Health Organization
Michael Gwarisa Argentina has announced its official withdrawal from the World Health Organization (WHO) citing irreparable differences. Through his official X account, Argentina’s presidential spokesperson Manuel Adorni said they had significant disagreements with WHO regarding management of the COVID-19 pandemic, the same reason given by US President Donald Trump for exiting the global health body.
Read More
FDA Draft Guidance on Flavored Vapes Aims to Protect Youth
Michael Gwarisa In a move likely to curb rising youth vaping in the Global North, the U.S. Food and Drug Administration (FDA) has issued new draft guidance for flavored electronic nicotine delivery systems (ENDS), establishing the first regulatory framework that emphasises device-level age verification to prevent underage use. Flavored ENDS have long been linked
Read More
New Global Research Grants Open for Mental Health Nurse Practitioners to Study Schizophrenia and Bipolar Disorder
Michael Gwarisa Pharmaceutical company Alkermes plc has unveiled a new research funding initiative aimed at supporting psychiatric nurse practitioners who are working to improve treatment for serious mental health conditions. The company announced that applications for the first Alkermes Pathways APN Research Awards™ will officially open on March 16, 2026, offering funding opportunities to advanced
Read More
New Single-Pill HIV Treatments Show Strong Results in Global Trials
Michael Gwarisa Two new once-daily HIV treatments taken as a single pill have shown strong results in late-stage clinical trials, raising hopes for simpler treatment options for people living with the virus. The studies were presented at the Conference on Retroviruses and Opportunistic Infections 2026 in Denver, United States. Researchers tested whether the new drugs
Read More